{"pmid":32362920,"pmcid":"PMC7189267","title":"Armarium facilitating angina management post myocardial infarction concomitant with coronavirus disease 2019.","text":["Armarium facilitating angina management post myocardial infarction concomitant with coronavirus disease 2019.","J Geriatr Cardiol","Cai, Xiao-Qing","Jiao, Pi-Qi","Wu, Tao","Chen, Fu-Ming","Han, Bao-Shi","Zhang, Jiu-Cong","Xiao, Yong-Jiu","Chen, Zhi-Feng","Li, Jun","Zhao, Yu-Ying","Ma, Ling","Liu, Yan","Shi, Ya-Jun","Dai, Pei-Jun","Chen, Yun-Dai","32362920"],"journal":"J Geriatr Cardiol","authors":["Cai, Xiao-Qing","Jiao, Pi-Qi","Wu, Tao","Chen, Fu-Ming","Han, Bao-Shi","Zhang, Jiu-Cong","Xiao, Yong-Jiu","Chen, Zhi-Feng","Li, Jun","Zhao, Yu-Ying","Ma, Ling","Liu, Yan","Shi, Ya-Jun","Dai, Pei-Jun","Chen, Yun-Dai"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32362920","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.11909/j.issn.1671-5411.2020.04.005","keywords":["acute myocardial infarction","angina","coronavirus disease 2019","electrocardiogram","stethoscope"],"topics":["Case Report"],"weight":1,"_version_":1666138496083951617,"score":9.490897,"similar":[{"pmid":32430631,"title":"Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient.","text":["Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient.","Clin Res Cardiol","Hinterseer, Martin","Zens, Martin","Wimmer, Roland Jean","Delladio, Simon","Lederle, Susanne","Kupatt, Christian","Hartmann, Bernd","32430631"],"journal":"Clin Res Cardiol","authors":["Hinterseer, Martin","Zens, Martin","Wimmer, Roland Jean","Delladio, Simon","Lederle, Susanne","Kupatt, Christian","Hartmann, Bernd"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32430631","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s00392-020-01663-4","keywords":["acute myocardial infarction","covid-19","respiratory failures","stent thrombosis"],"topics":["Case Report"],"weight":1,"_version_":1667342288383115264,"score":70.23747},{"pmid":32311816,"title":"Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","text":["Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option. This article is protected by copyright. All rights reserved.","Catheter Cardiovasc Interv","Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D","32311816"],"abstract":["The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option. This article is protected by copyright. All rights reserved."],"journal":"Catheter Cardiovasc Interv","authors":["Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311816","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/ccd.28946","keywords":["covid-19","stemi","acute myocardial infarction","emergency medical system","fibrinolysis","percutaneous coronary intervention"],"locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138491218558976,"score":67.08904},{"pmid":32330544,"pmcid":"PMC7173829","title":"Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","text":["Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option.","J Am Coll Cardiol","Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D","32330544"],"abstract":["The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option."],"journal":"J Am Coll Cardiol","authors":["Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330544","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jacc.2020.04.039","keywords":["covid-19","stemi","acute myocardial infarction","emergency medical system","fibrinolysis","percutaneous coronary intervention"],"locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138494629576708,"score":67.08904},{"pmid":32473051,"title":"Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.","text":["Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.","COVID-19 is a new viral infection that has a significant impact on global health and economy. Because of its rapid spread worldwide, it may influence the prognosis of other medical conditions, such as ST-segment elevation myocardial infarction (STEMI). We report a case of a 58-year female patient admitted with an infero-posterior STEMI on the background of recently positive COVID-19 swab. Reperfusion was attempted through primary PCI but unfortunately failed to restore coronary blood flow due to massive thrombotic burden despite several attempts of balloon dilatation and aspiration thrombectomy. She sadly died later on because of hemodynamic deterioration. This scenario raises concerns about Neutrophil Extracellular Traps (NETS) which might potentially have propagated inflammation and thrombosis via platelets' aggregation leading to enhanced coagulopathy and massive coronary thrombosis. Therefore, we suggest primary PCI as the first-choice of revascularization in patients with combined COVID-19 and STEMI. Additionally, we emphasize on the importance of using the potent new generation P2Y12 inhibitors along with GPIIb/IIIa inhibitors in every STEMI patient with COVID-19 to achieve favorable conditions for primary PCI as well as favorable outcomes after stent implantation.","Catheter Cardiovasc Interv","Seif, Sherif","Ayuna, Ahmed","Kumar, Abhishek","Macdonald, John","32473051"],"abstract":["COVID-19 is a new viral infection that has a significant impact on global health and economy. Because of its rapid spread worldwide, it may influence the prognosis of other medical conditions, such as ST-segment elevation myocardial infarction (STEMI). We report a case of a 58-year female patient admitted with an infero-posterior STEMI on the background of recently positive COVID-19 swab. Reperfusion was attempted through primary PCI but unfortunately failed to restore coronary blood flow due to massive thrombotic burden despite several attempts of balloon dilatation and aspiration thrombectomy. She sadly died later on because of hemodynamic deterioration. This scenario raises concerns about Neutrophil Extracellular Traps (NETS) which might potentially have propagated inflammation and thrombosis via platelets' aggregation leading to enhanced coagulopathy and massive coronary thrombosis. Therefore, we suggest primary PCI as the first-choice of revascularization in patients with combined COVID-19 and STEMI. Additionally, we emphasize on the importance of using the potent new generation P2Y12 inhibitors along with GPIIb/IIIa inhibitors in every STEMI patient with COVID-19 to achieve favorable conditions for primary PCI as well as favorable outcomes after stent implantation."],"journal":"Catheter Cardiovasc Interv","authors":["Seif, Sherif","Ayuna, Ahmed","Kumar, Abhishek","Macdonald, John"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473051","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/ccd.29050","keywords":["acute myocardial infarction","antithrombotic treatment","neutrophil extracellular traps","primary percutaneous coronary intervention","viral infection"],"topics":["Case Report"],"weight":1,"_version_":1668255193450414080,"score":65.276436},{"pmid":32405816,"pmcid":"PMC7220537","title":"Complicated myocardial infarction in a 99-year-old lady in the era of COVID-19 pandemic: from the need to rule out coronavirus infection to emergency percutaneous coronary angioplasty.","text":["Complicated myocardial infarction in a 99-year-old lady in the era of COVID-19 pandemic: from the need to rule out coronavirus infection to emergency percutaneous coronary angioplasty.","Intern Emerg Med","Sgura, Fabio Alfredo","Arrotti, Salvatore","Cappello, Carlo Giuseppe","Boriani, Giuseppe","32405816"],"journal":"Intern Emerg Med","authors":["Sgura, Fabio Alfredo","Arrotti, Salvatore","Cappello, Carlo Giuseppe","Boriani, Giuseppe"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405816","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s11739-020-02362-8","keywords":["acute myocardial infarction","coronavirus","elderly","emergency","infection","percutaneous coronary intervention"],"topics":["Case Report"],"weight":1,"_version_":1666950579798147074,"score":64.99547}]}